<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E27575EF-ABFB-484B-BEEF-53343150A49E"><gtr:id>E27575EF-ABFB-484B-BEEF-53343150A49E</gtr:id><gtr:name>Bill and Melinda Gates Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2D4AF1D8-F4EE-4040-93AB-658DF7F13D2C"><gtr:id>2D4AF1D8-F4EE-4040-93AB-658DF7F13D2C</gtr:id><gtr:name>Tulane University</gtr:name><gtr:address><gtr:line1>6823 St Charles Avenue</gtr:line1><gtr:line4>New Orleans</gtr:line4><gtr:line5>Louisianna</gtr:line5><gtr:postCode>LA 70118</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D4584B27-3F2A-4408-B3E3-19B6800F5217"><gtr:id>D4584B27-3F2A-4408-B3E3-19B6800F5217</gtr:id><gtr:name>Amsterdam Institute for Global Health and Development (AIGHD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF94AA14-BBB6-40D1-8FBC-94CF531FE138"><gtr:id>BF94AA14-BBB6-40D1-8FBC-94CF531FE138</gtr:id><gtr:name>Intellectual Ventures</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E27575EF-ABFB-484B-BEEF-53343150A49E"><gtr:id>E27575EF-ABFB-484B-BEEF-53343150A49E</gtr:id><gtr:name>Bill and Melinda Gates Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D4AF1D8-F4EE-4040-93AB-658DF7F13D2C"><gtr:id>2D4AF1D8-F4EE-4040-93AB-658DF7F13D2C</gtr:id><gtr:name>Tulane University</gtr:name><gtr:address><gtr:line1>6823 St Charles Avenue</gtr:line1><gtr:line4>New Orleans</gtr:line4><gtr:line5>Louisianna</gtr:line5><gtr:postCode>LA 70118</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D4584B27-3F2A-4408-B3E3-19B6800F5217"><gtr:id>D4584B27-3F2A-4408-B3E3-19B6800F5217</gtr:id><gtr:name>Amsterdam Institute for Global Health and Development (AIGHD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF94AA14-BBB6-40D1-8FBC-94CF531FE138"><gtr:id>BF94AA14-BBB6-40D1-8FBC-94CF531FE138</gtr:id><gtr:name>Intellectual Ventures</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/795687DA-AFB2-461C-A43D-74D5E6600413"><gtr:id>795687DA-AFB2-461C-A43D-74D5E6600413</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Guy</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:orcidId>0000-0003-4410-6635</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802414"><gtr:id>E7024FA1-4272-4F14-9E30-D60EFDFA5288</gtr:id><gtr:title>Respondent-driven sampling: empirical evaluation and methodological development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802414</gtr:grantReference><gtr:abstractText>A new method of gathering data on vulnerable groups in society has been proposed, called Respondent Driven Sampling. 

Research is needed to assess how well Respondent Driven Sampling works in collecting high-quality data, and also to explore if the method could be improved. 

This research will test whether Respondent Driven Sampling works in London university students and fishermen in Uganda. It will also evaluate and extend the theory on which Respondent Driven Sampling is based using state-of-the-art statistical inference and computational modelling

If Respondent Driven Sampling can be shown to work well, it will allow researchers and public heath workers to monitor trends in highly-vulnerable groups such as sex-workers and injecting drug users. Data that could be used, for example, to see whether HIV prevention programs in these groups are succeeding or failing.</gtr:abstractText><gtr:technicalSummary>Background 
Respondent Driven Sampling(RDS) has recently been proposed as a method of collecting unbiased representative data on Hidden or hard-to-reach population subgroups that are often key to the maintenance of infectious diseases in human populations. RDS estimation theory is based on a non-standard, indirect, procedure that first makes inferences about the sample population?s social network and then makes inferences about the target population. 

This non-standard approach has hindered the methodological development and validation of RDS and, to date, only one study has attempted to evaluate RDS by comparing data collected using RDS with representative contemporaneous data from the same population. This study, an internet-based RDS survey of Cornell university students, failed to estimate the proportion male within the method?s 95% plausible range, reinforcing earlier concerns that RDS may not generate representative data, even in easily-accessible populations. Despite this, RDS has quickly become popular, over 123 RDS studies have been published and RDS is also being employed to provide data for public health decision making by major funding bodies (Centers for Disease Control and Prevention and Family Health International).

RDS has the potential to address important epidemiological issues, but the theoretical basis of RDS is poorly understood and the key statistical questions remain unanswered. There is an urgent need to empirically validate RDS and develop appropriate statistical methods to analyse data collected using RDS.

Aim
The aim of this Fellowship is to evaluate whether RDS can generate representative population-based samples and to further develop the methodology required to analyze data collected in RDS studies. 

Objectives
1. To validate face-to-face RDS among fishermen in rural Uganda using representative population-based data as the gold standard 
Design: Compare a cross-sectional RDS sample of 600 fishermen in rural Uganda wiepresentative population based data.
2. To validate internet-based RDS among London graduate students using whole-population institutional data as the gold standard, and to explore the impact of temporal filtering. 
Design: Two cross-sectional web-based RDS surveys, each collecting data on 500 students in the same London University.
3. To evaluate and extend the theory on which RDS is based using the results of (1) and (2) and state-of-the-art statistical inference and computational modelling by:
 a. Assessing the performance of the existing RDS point and interval estimators and seek to identify alternative estimators that offer improved performance. 
Design: Methodological development and statistical modelling using STATA, WinBUGS, R and Matlab.
 b. Use simulation network modelling to assess the characteristics of at-risk populations and RDS survey strategies for which RDS is most able to generate representative data. 
Design: Network simulation modelling using C++.
4. To produce practical recommendations for researchers to conduct RDS studies in a ?Toolkit?; Outputs: Toolkit and documentation on custom functions in standard statistics analyis packages
5. To initiate further studies to validate RDS using representative data on hidden populations. Proposed design: Comparison of data from cross sectional face-to-face RDS studies with representative samples on the same hidden population</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>400574</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>HIV Modelling Consortium</gtr:description><gtr:id>0FB07CAF-0226-4D3A-86D8-FC41E7469E0D</gtr:id><gtr:impact>Group funding: TB Alliance and Aeras project grants
Publications
Research ideas</gtr:impact><gtr:outcomeId>ZGEWLAntDmb-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC/UVRI Uganda Research Unit on AIDS</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Empirical evaluation of RDS in rural Uganda</gtr:description><gtr:id>2B6255E0-FC23-4DAD-A302-604F516E5E5D</gtr:id><gtr:impact>Dissemination of results to participants in research
Multidisciplinary: Epidemiology, Statistics, Mathematics, Social Science.</gtr:impact><gtr:outcomeId>jnewgPv5sEU-1</gtr:outcomeId><gtr:partnerContribution>The fieldwork I conducted in Uganda relied critically on the research infrastructure of this MRC Unit, including access to data, equipment and facilities and training of staff.Significant intellectual input into research designSignificant intellectual input into research designAdvice on RDS fieldwork</gtr:partnerContribution><gtr:piContribution>PI of research project. Wrote protocol. Trained staff. Supervised fieldwork and research staff. Analysed data. Led publication drafting.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tulane University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Public Health Tulane</gtr:department><gtr:description>Empirical evaluation of RDS in rural Uganda</gtr:description><gtr:id>B2C5D2EB-CAB4-47E1-96BB-7F15209F07DF</gtr:id><gtr:impact>Dissemination of results to participants in research
Multidisciplinary: Epidemiology, Statistics, Mathematics, Social Science.</gtr:impact><gtr:outcomeId>jnewgPv5sEU-4</gtr:outcomeId><gtr:partnerContribution>The fieldwork I conducted in Uganda relied critically on the research infrastructure of this MRC Unit, including access to data, equipment and facilities and training of staff.Significant intellectual input into research designSignificant intellectual input into research designAdvice on RDS fieldwork</gtr:partnerContribution><gtr:piContribution>PI of research project. Wrote protocol. Trained staff. Supervised fieldwork and research staff. Analysed data. Led publication drafting.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intellectual Ventures</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>CB7CEC60-C888-4D93-B618-80DB07A44E62</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-4</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bill and Melinda Gates Foundation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>3AD1FC71-38D7-4DF0-9B7B-62C807FE38DF</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-5</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Department of Control of Neglected Tropical Diseases (NTD)</gtr:department><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>477B8D77-CDCF-42A4-B2B2-E7EE3B9EE754</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-1</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Empirical evaluation of RDS in rural Uganda</gtr:description><gtr:id>FB866178-A09B-43D0-A899-5CEA564E3304</gtr:id><gtr:impact>Dissemination of results to participants in research
Multidisciplinary: Epidemiology, Statistics, Mathematics, Social Science.</gtr:impact><gtr:outcomeId>jnewgPv5sEU-2</gtr:outcomeId><gtr:partnerContribution>The fieldwork I conducted in Uganda relied critically on the research infrastructure of this MRC Unit, including access to data, equipment and facilities and training of staff.Significant intellectual input into research designSignificant intellectual input into research designAdvice on RDS fieldwork</gtr:partnerContribution><gtr:piContribution>PI of research project. Wrote protocol. Trained staff. Supervised fieldwork and research staff. Analysed data. Led publication drafting.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Johns Hopkins Bloomberg School of Public Health</gtr:department><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>A06D5C8B-8F76-4729-BBC2-9EA971BB2984</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-3</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>33AAAE6D-0D40-46CC-BFDD-34656E5F8009</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-6</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Amsterdam Institute for Global Health and Development (AIGHD)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>TB Diagnostics Forum Modelling Workgroup</gtr:description><gtr:id>784EF524-3138-430E-A768-D19B10B56C27</gtr:id><gtr:impact>Publications. 
Target Product Profiles of new diagnostics.</gtr:impact><gtr:outcomeId>MAG419PAiQZ-2</gtr:outcomeId><gtr:partnerContribution>JHU leads the working group. AIGHD provides scientific input.</gtr:partnerContribution><gtr:piContribution>Intellectual input to discussions on characteristics of desired target product profiles for new diagnostics</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>TB Diagnostics Forum Modelling Workgroup</gtr:description><gtr:id>76FED523-41FF-4AA5-9379-0E5DEC1B82BE</gtr:id><gtr:impact>Publications. 
Target Product Profiles of new diagnostics.</gtr:impact><gtr:outcomeId>MAG419PAiQZ-1</gtr:outcomeId><gtr:partnerContribution>JHU leads the working group. AIGHD provides scientific input.</gtr:partnerContribution><gtr:piContribution>Intellectual input to discussions on characteristics of desired target product profiles for new diagnostics</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>TB Modelling and Analysis Consortium</gtr:description><gtr:id>EF74EE3D-2AFD-47E6-8C59-8BA141214A1A</gtr:id><gtr:impact>Huge amount of outputs, please see other sections of report
Publications in Modelling research agenda, TB Diagnostics
Impact on Policy, Govt Budgets, and Research Priorities in South Africa</gtr:impact><gtr:outcomeId>gKW4xpemSBb-2</gtr:outcomeId><gtr:partnerContribution>Has resulted in significant intellectual and in-kind research time of many other research groups input to my groups research (e.g. Global TB Targets work was a collaboration of 11 international research groups contributing results to this research question, largely unfunded).</gtr:partnerContribution><gtr:piContribution>Intellectual and meeting organisational input. 
This consortium funds 50% of my time and 100% of two of my group members (1 research, 1 admin).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Training public health professionals in Infectious Disease Modelling</gtr:description><gtr:id>9C25D615-9616-43DE-96E8-D14DE246A132</gtr:id><gtr:impact>Published book used for training public health researchers in Infectious Disease Modelling.
Multidisciplinary: Epidemiology, Demography, Statistics and Mathematics.</gtr:impact><gtr:outcomeId>k8xGjiwnybh-1</gtr:outcomeId><gtr:partnerContribution>Wrote book and modelling courses. Run courses each year.</gtr:partnerContribution><gtr:piContribution>Wrote book and modelling courses. Run courses each year.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Empirical evaluation of RDS in rural Uganda</gtr:description><gtr:id>039C6BAB-C1D8-41D7-B6F5-0999DFD1BDD7</gtr:id><gtr:impact>Dissemination of results to participants in research
Multidisciplinary: Epidemiology, Statistics, Mathematics, Social Science.</gtr:impact><gtr:outcomeId>jnewgPv5sEU-3</gtr:outcomeId><gtr:partnerContribution>The fieldwork I conducted in Uganda relied critically on the research infrastructure of this MRC Unit, including access to data, equipment and facilities and training of staff.Significant intellectual input into research designSignificant intellectual input into research designAdvice on RDS fieldwork</gtr:partnerContribution><gtr:piContribution>PI of research project. Wrote protocol. Trained staff. Supervised fieldwork and research staff. Analysed data. Led publication drafting.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dissemination of results to participants in research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>025B88C4-8489-4B98-9308-96A77B175DA3</gtr:id><gtr:impact>About 20 community leaders representing the villages surveyed in the Empirical RDS evaluation attended a dissemination meeting. 
Led to many questions and discussion of results.

Community leaders were very interested in results and the session increased understanding of RDS and (in conjunction with on-going community activities by the MRC Uganda Unit) increased motivation for engaging in this and other research activities.</gtr:impact><gtr:outcomeId>qqztqpYeprz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TB vaccines press release (International 2013)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6B9FF096-72AD-4999-B108-45FE722087D0</gtr:id><gtr:impact>Led to reporting by 5 news organizations internationally

None</gtr:impact><gtr:outcomeId>RVwTezypHEE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TB vaccines press release (International 2013)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3842B32B-3112-4A25-9917-5F58272375B7</gtr:id><gtr:impact>Led to interview with leading US newswire service and story reported in 100s of newspapers and news outlets worldwide, mostly in the US

The potential damage that a negative finding from a vaccine trial was mitigated to some (unmeasured) extent and hopefully public support for TB vaccine trials was maintained.</gtr:impact><gtr:outcomeId>GnRHut5Kgg6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TB vaccines film documentary (International 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>42216A05-52C9-42DB-AAD2-320AA5068287</gtr:id><gtr:impact>I was interviewed and included in 2 short easily assessable films made on need for TB vaccine research. Films show internationally to public, policy, funder and academic audiences.

Films have been shown to parliamentarians, policy makers, funder (eg European Investment Bank) and the general public. Has increased support for TB vaccine development at a time when a negative trial was announced and cuts were expected.</gtr:impact><gtr:outcomeId>QBzktyJhncY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.aeras.org/exposed</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>248747</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>United States President's Emergency Plan for AIDS Relief (PEPFAR)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>United States President's Emergency Plan for AIDS Relief (PEPFAR)</gtr:fundingOrg><gtr:fundingRef>U2GPS0008111</gtr:fundingRef><gtr:id>90888FD8-E712-4403-90F3-8BCFEEBAAFEE</gtr:id><gtr:outcomeId>TCQnH7yo5CE</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Aeras project grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Aeras</gtr:fundingOrg><gtr:id>3C826336-29DF-479A-AAC8-75AEF2EA37A0</gtr:id><gtr:outcomeId>oYLFMPsTe5U</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>439000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Bill and Melinda Gates Foundation: Global Health: Tuberculosis</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef> 21675</gtr:fundingRef><gtr:id>D0847A08-2ED9-4FBF-A1B1-28FA1495C275</gtr:id><gtr:outcomeId>AurK5AqPwB8</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>TB Alliance project grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>The Global Alliance for TB Drug Development</gtr:fundingOrg><gtr:id>87BE56D8-A1A5-474C-AB10-63DE03A847CE</gtr:id><gtr:outcomeId>gX2JB9JTQ5e</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>264107</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>242061</gtr:fundingRef><gtr:id>F6254AD0-3FC0-4328-A4C6-D1CB092D397A</gtr:id><gtr:outcomeId>RHiR2bwtqqU0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2300000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Bill and Melinda Gates Foundation: Global Health: Tuberculosis</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1084276</gtr:fundingRef><gtr:id>BFD4B4B3-ACC2-4168-8C1C-7B2BA58BFD30</gtr:id><gtr:outcomeId>MNGn9TvXEhZ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>640102</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant awarded by MRC/NIHR Methodology Research Panel</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J005088/1</gtr:fundingRef><gtr:id>FB6D607C-0DA8-4770-9C8E-98A9CF41439F</gtr:id><gtr:outcomeId>P9HsA2TC1P60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>309444</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CR-UK</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>614F4319-A364-4106-8E14-99F671E70B54</gtr:id><gtr:outcomeId>X7HNV53roeW0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Aeras studentship grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Aeras</gtr:fundingOrg><gtr:id>D293EDBA-1BEA-412D-9E2F-2CA9FBD0130E</gtr:id><gtr:outcomeId>545fd691ba8b40.96417219</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>WHO</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:id>2D02F490-B185-4819-BABA-47F804464EA5</gtr:id><gtr:outcomeId>foGSYffRvDX</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Bill and Melinda Gates Foundation: Global Health: Tuberculosis</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1110334</gtr:fundingRef><gtr:id>7027E097-7C14-4617-ACC1-4F63F79D3DB9</gtr:id><gtr:outcomeId>545fd58018ae98.12532484</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1499000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>USAID TB Treat Grant</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>United States Agency for International Development</gtr:fundingOrg><gtr:fundingRef>GHN-A-OO-08-00004-00</gtr:fundingRef><gtr:id>178F6C10-A2F9-4BC7-BF9F-46258C23A13A</gtr:id><gtr:outcomeId>545fd64268c327.99894864</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We created a user-friendly tool (a mathematical model) for TB-HIV control projections and costing. This tool will be freely available for download by country-level TB/HIV policy makers for decision making on TB control strategies and costing in 2015. It has been used in workshops run by UNAIDS, the Global Fund, WHO and at country level.</gtr:description><gtr:grantRef>G0802414</gtr:grantRef><gtr:id>216044A0-CBBE-4C62-8FE6-6E9FF0823424</gtr:id><gtr:impact>I was released globally in 2015. So far used to update Sudan, Bangladesh and Vietnam National Strategic Plan in 2013/4 (in Sudan: it led to a move to more decentralized provision of TB patient care), and in South Africa, Ghana and Nigeria. It will be used in about ~5 more high TB burden countries in 2016.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>tLT9MktD3ob</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>New user-friendly country-level tool for TB-HIV control projections and costings</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO/South African Department of Health Tuberculosis Meeting</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>19546394-9743-4251-BF7A-EFA6B0947E85</gtr:id><gtr:impact>This and subsequent meetings lead to a change in the South Africa Govt's National Strategic Plan policy to include continuous Isoniazid Preventive Therapy (IPT) to HIV infected individuals. IPT greatly reduces mortality in HIV infected individuals. This will have a near immediate impact on survival / morbidity / quality of life in HIV+ South Africans.</gtr:impact><gtr:outcomeId>bgj1t7jQDgf</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organised Symposium on RDS at International STI meeting to help STI practioners and researchers understand the current limitations of data collected using RDS</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>057A0B02-8511-4C55-884A-9CE7E881C2D4</gtr:id><gtr:impact>Much verbal feedback during and afterwards that symposium greatly helped practioners and researchers better understand the current limitations of RDS.
Editorial written based on this symposium with the aim of influencing policy regarding the interpretation of data collected using RDS.
It also included the first guidelines for the reporting of RDS studies (STROBE-RDS).</gtr:impact><gtr:outcomeId>DkfyomnpXgr</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Published Introductory Infectious Disease Modelling book for training clinicians, epidemiologists and public health professionals</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>272FF10D-1B88-4F7D-8F39-88B1272F3C9E</gtr:id><gtr:impact>The book has sold well (~2000 copies by mid 2013) and widely (Africa, Australia, Eurasia, North and South America) since its release in May 2010. 
The book is accompanied by extensive exercises and training materials that have been downloaded over 500 times by mid 2013(http://anintroductiontoinfectiousdiseasemodelling.com/). 
Material from the book have been directly incorporated into at numerous university courses, including the Harvard and Princeton.
This will have directly affected the ability of these students and public health professionals to interpret and use mathematical modelling in their work.</gtr:impact><gtr:outcomeId>TmKdMCX8fdd</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://anintroductiontoinfectiousdiseasemodelling.com/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence used to set WHO post-2015 Global TB Targets</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A2597087-6F8F-4B59-9CCC-375A03B3FE48</gtr:id><gtr:impact>My group generated evidence that was used to set ambitious WHO post 2015 global TB targets. This should have major impact on TB financing and control policies and practice over the next 15 years.</gtr:impact><gtr:outcomeId>nVUoUSFETAi</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Course - Introduction to impact and economics of TB control</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>15AE89D8-C283-4F68-91E1-B5055C97F861</gtr:id><gtr:impact>Trained medical professionals in quantitative methods to use in their decision making at country and global level.</gtr:impact><gtr:outcomeId>FDx5XfqG6GL</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Led creation of 'STROBE-RDS': Reporting Guidelines for Respondent Driven Sampling Surveys</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C12B0A6-65A9-4FC9-B086-37E019A49B4B</gtr:id><gtr:impact>Peer reviewed reporting guidelines have been published, have been incorporated into submission guidelines for at least two academic journals (2016), have already been cited in papers reporting findings from RDS surveys. 
This will increase the value of data collected using RDS. This should lead to improved health and funding decisions targeted (primarily) at the control and prevention of HIV, and later, improved survival, morbidity and quality of life, and the efficiency of health care delivery.</gtr:impact><gtr:outcomeId>Zu2kzq25jLy</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/26112433</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Set up Infectious Disease Modelling Course in Distance Learning format for training health professionals (particularly busy professionals outside the UK)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C83B993C-8E98-43A3-9F0D-38818AAEBFB6</gtr:id><gtr:impact>Course mirrors my earlier successful release of the two face-to-face LSHTM Infectious Disease Modelling courses and an Introductory Infectious Disease Modelling book (2010).

As with the earlier courses and the book, the course is accompanied by extensive exercises and training materials designed to enable students and public health professionals to interpret and use mathematical modelling in their day to day practice.

The conversion of this material to Distance Learning format will enable</gtr:impact><gtr:outcomeId>PXstB9rfhgX</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Global Fund Distribution of Funding by Disease</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>849A8F60-5BA5-4D98-A3D6-AF09E26520D2</gtr:id><gtr:impact>I directly contributed to debate and the (eventual) consensus that led to an increase in proportion of funds allocated by the Global Fund to Tuberculosis. Global reach. Should increase survival and morbidity by reducing TB disease (no quantitative evidence yet)</gtr:impact><gtr:outcomeId>UATkwty1fUV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We created a new statistical analysis method that uses data collected from recruiters in RDS studies to reduce bias. This technique has been shared by publication.</gtr:description><gtr:id>A3B900ED-7626-4A83-9238-B8FD854244F7</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>545fc3726f8004.14730722</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New statistical method for Respondent Driven Sampling</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0078402</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>We created a user-friendly tool (a mathematical model) for TB-HIV control projections and costing. This tool is for use by country-level TB/HIV policy makers for decision making on TB control strategies and costing. It has been used in workshops at Global level by UNAIDS, the Global Fund and WHO, and at country level in South Africa, Viet Nam, Ghana, Nigeria.</gtr:description><gtr:id>0BC3E545-CEB4-443B-A6BA-4C44FBE83569</gtr:id><gtr:impact>It was rolled out globally in 2015. So far it has been used by my group to update the Sudan, Bangladesh and Vietnam National Strategic Plan in 2013/4 (in Sudan, a move to more decentralized provision of TB patient care), and in Ghana, Nigeria. It will be used in about ~5 more high TB burden countries in 2016.</gtr:impact><gtr:outcomeId>545fc2e28e2693.84466749</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New user-friendly country-level modelling tool for TB-HIV control projections and costings</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://www.avenirhealth.org/software-spectrum</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>The developed method allows the calibration of multi-input, multi-output agent based computer models of high complexity. The method is based
on a statistical approximation of the computer model, called the emulator, and tries to identify regions of the input space that are likely to lead to
a match between the model's outputs and the calibration data. The computational efficiency of the emulator makes this method very applicable to
computer models with long running times.</gtr:description><gtr:id>83B2689B-6A51-43C8-B88E-E60CEF05E78C</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>545fc5d1bd4811.62636240</gtr:outcomeId><gtr:title>History matching of complex agent based computer models using emulation</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://cmmid.lshtm.ac.uk/mrccalib/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>We created a user-friendly tool (a mathematical model) for TB-HIV control projections and costing. This tool is for use by country-level TB/HIV
policy makers for decision making on TB control strategies and costing. It has been used in workshops run by UNAIDS, the Global Fund and WHO
over the coming years.</gtr:description><gtr:id>98E55A3A-F5A7-4231-AF80-3FED8C4DC5D2</gtr:id><gtr:impact>It was released globally in 2015. So far used to update the Government of Sudan, Bangladesh and Vietnam National Strategic Plan in 2013/4 (in Sudan, a move to more decentralized provision of TB patient care), South Africa, Ghana and Nigeria. It will be used in ~5 more high TB burden countries in 2016.</gtr:impact><gtr:outcomeId>545fc6142ce6a6.33730351</gtr:outcomeId><gtr:title>New user-friendly country-level modelling tool for TB-HIV control projections and costings</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.avenirhealth.org/software-spectrum</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Avenir Health</gtr:companyName><gtr:description>Futures Institute, founded in 2006, is a global health organization that works to enhance social and economic development by providing tools and technical assistance in policy, planning, resource allocation and evaluation. In particular, we focus on developing and implementing demographic, epidemiological and costing models for long-range planning to assist with setting goals, strategies, and objectives. We assist in both developing and implementing programs in HIV/AIDS, reproductive health, maternal health and other programming areas. We work with government agencies, foundations, corporations, and nongovernmental organizations around the world.

Areas of program concentration include family planning and reproductive health, maternal and child health, the prevention and treatment of HIV/AIDS, and infectious diseases. With staff based in the United States and Africa, we work collaboratively with our in-country counterparts to improve policies and programs that address population issues, reproductive health, HIV/AIDS, infectious diseases, and maternal and child health.</gtr:description><gtr:id>F36FA374-5356-4DAE-9284-DF5CA8B9CF44</gtr:id><gtr:impact>Impacts are many and varied across a variety of health sectors. 
Impacts that my (Tuberculosis) work with them has supported includes:
1) generating country-level TB/HIV estimates for the WHO report 2013 and 2014, 
3) Generating evidence for the STOPTB/WHO Tuberculosis Global Plan (2015) - global resource needs estimates, that are used to motivate for funding from international partners (Gates, Global Fund, ...)
3) Futures working with countries to develop TB/HIV National Strategic Plans in 3+ countries globally, affecting governmental TB/HIV strategies and resource allocation within these 3 countries. 
This is an active and growing collaboration and much more activity will happen over the next 12 months.</gtr:impact><gtr:outcomeId>545fc97b41a688.48707297</gtr:outcomeId><gtr:url>http://www.avenirhealth.org/</gtr:url><gtr:yearCompanyFormed>2006</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>4BD9094F-54D4-4A3C-A072-BE0C1205F23F</gtr:id><gtr:title>Polygyny and symmetric concurrency: comparing long-duration sexually transmitted infection prevalence using simulated sexual networks.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5493212173eed645eaa1ea26c9106ae"><gtr:id>f5493212173eed645eaa1ea26c9106ae</gtr:id><gtr:otherNames>Santhakumaran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>h6w7UWiFUr8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D95D6B59-1EE9-4256-B867-247606864CCB</gtr:id><gtr:title>Modelling the HIV epidemic among MSM in the United Kingdom: quantifying the contributions to HIV transmission to better inform prevention initiatives.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c113baf3e8d44f6e5888d0d5a61caf2"><gtr:id>4c113baf3e8d44f6e5888d0d5a61caf2</gtr:id><gtr:otherNames>Punyacharoensin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>doi_55f984984fa50f50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E81C0683-3ABA-4090-9312-B980A2CE3FAA</gtr:id><gtr:title>Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: &amp;quot;STROBE-RDS&amp;quot; statement.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9671f0547378b4422b992b3ea8b9c2b2"><gtr:id>9671f0547378b4422b992b3ea8b9c2b2</gtr:id><gtr:otherNames>White RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56c8a3661eb383.07195037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F96C04C-6A83-49AF-927B-F5DDF2599A8A</gtr:id><gtr:title>Transmission potential of Rift Valley fever virus over the course of the 2010 epidemic in South Africa.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f0498ce56338356b43a234d102ad97f"><gtr:id>2f0498ce56338356b43a234d102ad97f</gtr:id><gtr:otherNames>M?tras R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_12563_23_23735606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54094E0D-3169-44C4-BDF3-7A471413A507</gtr:id><gtr:title>Respondent driven sampling--where we are and where should we be going?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9671f0547378b4422b992b3ea8b9c2b2"><gtr:id>9671f0547378b4422b992b3ea8b9c2b2</gtr:id><gtr:otherNames>White RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_12563_23_23012492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3D96801-5810-4F2B-ADC7-CC528EDC0AB6</gtr:id><gtr:title>Community understanding of Respondent-Driven Sampling in a medical research setting in Uganda: importance for the use of RDS for public health research.</gtr:title><gtr:parentPublicationTitle>International journal of social research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1364-5579</gtr:issn><gtr:outcomeId>Fj5UqhA3PJA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9409EA6C-A034-4168-BC5F-76B69702072A</gtr:id><gtr:title>Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b98ae86d3ecb351864f1a74fe0245c95"><gtr:id>b98ae86d3ecb351864f1a74fe0245c95</gtr:id><gtr:otherNames>Chapman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>AdpQ5ef37Eg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97525411-F522-40F3-BF5E-4B9E33D40528</gtr:id><gtr:title>Does the 'inverse equity hypothesis' explain how both poverty and wealth can be associated with HIV prevalence in sub-Saharan Africa?</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83c90920ebb2c122fb1355f3d53131cb"><gtr:id>83c90920ebb2c122fb1355f3d53131cb</gtr:id><gtr:otherNames>Hargreaves JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn><gtr:outcomeId>PXrzkW99G6K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>809A1D13-3D74-41F9-99FD-DABE8A2B4C10</gtr:id><gtr:title>Respondent driven sampling: determinants of recruitment and a method to improve point estimation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_12563_ne_0078402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B0BBD5-89FC-43B0-8455-4456A80C9076</gtr:id><gtr:title>Periodic active case finding for TB: when to look?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8fa3e311c4f6e1e8f3a5e0ddf1c1d88"><gtr:id>a8fa3e311c4f6e1e8f3a5e0ddf1c1d88</gtr:id><gtr:otherNames>Dodd PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545fb2053b3560.92465799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD424752-4080-4899-96D7-5864F7429D0E</gtr:id><gtr:title>The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b8de042e1b2ed47584a5aca506c015"><gtr:id>92b8de042e1b2ed47584a5aca506c015</gtr:id><gtr:otherNames>Shafer LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>545f9fb0babe60.07887631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3419B6C3-B65B-4E07-BD52-79BEAA2148AE</gtr:id><gtr:title>Evaluation of the role of location and distance in recruitment in respondent-driven sampling.</gtr:title><gtr:parentPublicationTitle>International journal of health geographics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1476-072X</gtr:issn><gtr:outcomeId>YZtt1NxAbXj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74DD583B-47E2-4BB0-87A1-8E6454DEE61B</gtr:id><gtr:title>Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8fa3e311c4f6e1e8f3a5e0ddf1c1d88"><gtr:id>a8fa3e311c4f6e1e8f3a5e0ddf1c1d88</gtr:id><gtr:otherNames>Dodd PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>56c8a3667f2df6.37998747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED412DF4-DB14-4601-A790-85C596BCF332</gtr:id><gtr:title>Rift Valley fever epidemiology, surveillance, and control: what have models contributed?</gtr:title><gtr:parentPublicationTitle>Vector borne and zoonotic diseases (Larchmont, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f0498ce56338356b43a234d102ad97f"><gtr:id>2f0498ce56338356b43a234d102ad97f</gtr:id><gtr:otherNames>M?tras R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1530-3667</gtr:issn><gtr:outcomeId>gH8nXzoqYkq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED643AC8-D557-471D-80D6-F386AC066939</gtr:id><gtr:title>HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2d9dd32848388e8a5ff188f90620ae3"><gtr:id>d2d9dd32848388e8a5ff188f90620ae3</gtr:id><gtr:otherNames>Baggaley RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>MTp7Y1Q8FPz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E44A4A1-E02C-4F2F-B5AA-A5A5B1C653DD</gtr:id><gtr:title>Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008-2011.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f0498ce56338356b43a234d102ad97f"><gtr:id>2f0498ce56338356b43a234d102ad97f</gtr:id><gtr:otherNames>M?tras R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_12563_23_22953020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A71BD780-95CC-4FAD-A175-50A76499A1B1</gtr:id><gtr:title>Attaining realistic and substantial reductions in HIV incidence: model projections of combining microbicide and male circumcision interventions in rural Uganda.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72d93573b3d4d7e99a88dd575e608349"><gtr:id>72d93573b3d4d7e99a88dd575e608349</gtr:id><gtr:otherNames>Cox AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>PSvMY73oeAs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7112DE0-35BF-4D87-A6B9-DBB5D5635A8E</gtr:id><gtr:title>Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8fa3e311c4f6e1e8f3a5e0ddf1c1d88"><gtr:id>a8fa3e311c4f6e1e8f3a5e0ddf1c1d88</gtr:id><gtr:otherNames>Dodd PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545fa276403d94.94798685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B8CB917-BA36-4779-B5C9-BB9BE5792FEF</gtr:id><gtr:title>Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df45bbde2fa354f91b34a4853de41aac"><gtr:id>df45bbde2fa354f91b34a4853de41aac</gtr:id><gtr:otherNames>Eaton JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>54612d727fc570.89112181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F5B809-E7C3-46A9-85A0-A6284977D767</gtr:id><gtr:title>Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>56c8a366ad50b5.34793682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75D8D2A3-9CF9-4948-9C73-10F21F207827</gtr:id><gtr:title>Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5a2fd7b5303007.73572594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BE0E561-1D47-493C-9AF6-4A2471510F27</gtr:id><gtr:title>Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/479a684ce45ca3605e84ac4ef3578925"><gtr:id>479a684ce45ca3605e84ac4ef3578925</gtr:id><gtr:otherNames>Vynnycky E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>doi_55f984984f9bba60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC2DC1B0-4C16-4BC5-93A8-CD84E2D97050</gtr:id><gtr:title>Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8beeebc1b4df2e53955a561c18ee4b83"><gtr:id>8beeebc1b4df2e53955a561c18ee4b83</gtr:id><gtr:otherNames>Zwerling A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54612aad3c6960.46600213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE78B0D-3F92-4384-A7C3-6CE06A1B77DF</gtr:id><gtr:title>Bayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7274488260ddc258bbee065fa1edd48"><gtr:id>e7274488260ddc258bbee065fa1edd48</gtr:id><gtr:otherNames>Andrianakis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>544e4d2b3d1995.26579893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1C84F0B-0956-43B0-92EE-B968435C3C9B</gtr:id><gtr:title>Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d695244fcb5f5bfadcb4706a050fccc"><gtr:id>5d695244fcb5f5bfadcb4706a050fccc</gtr:id><gtr:otherNames>Kranzer K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>msHkbcWEAuZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>744A1767-EFCD-490A-BDB1-539F8732ABE3</gtr:id><gtr:title>The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c8c2e55290f83c8645b954dd2ca494"><gtr:id>29c8c2e55290f83c8645b954dd2ca494</gtr:id><gtr:otherNames>Pretorius C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>545f9f43e99b38.13136564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23218CA6-5604-46B2-AD1B-EDCCB5972DB4</gtr:id><gtr:title>Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2d9dd32848388e8a5ff188f90620ae3"><gtr:id>d2d9dd32848388e8a5ff188f90620ae3</gtr:id><gtr:otherNames>Baggaley RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>545fa3b6e77c53.23479596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>453116D3-FA71-4DDD-807F-AC9BAF3A06B3</gtr:id><gtr:title>Estimation of the HIV basic reproduction number in rural south west Uganda: 1991-2008.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99395ac8117237f19900fd97f4502674"><gtr:id>99395ac8117237f19900fd97f4502674</gtr:id><gtr:otherNames>Nsubuga RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545fa012771721.69787252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CDD10AF-A305-434A-9A5E-9543E9F1A039</gtr:id><gtr:title>Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5a2fd5f3969239.11792517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70FC4F61-F8D4-4ACC-B2A2-9E4F1E9FE4D1</gtr:id><gtr:title>Mathematical models for the study of HIV spread and control amongst men who have sex with men.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c113baf3e8d44f6e5888d0d5a61caf2"><gtr:id>4c113baf3e8d44f6e5888d0d5a61caf2</gtr:id><gtr:otherNames>Punyacharoensin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn><gtr:outcomeId>dtF3v5cQ8Jb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C185078-0648-4E81-82A5-F76C795D2ABC</gtr:id><gtr:title>A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.</gtr:title><gtr:parentPublicationTitle>AIDS and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c47a9ba2fb02063c180abd218f801084"><gtr:id>c47a9ba2fb02063c180abd218f801084</gtr:id><gtr:otherNames>Johnston LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1090-7165</gtr:issn><gtr:outcomeId>58c1228f14d0b1.95325562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49741B5C-79E0-44C4-A79E-EACDDDBE23CC</gtr:id><gtr:title>HIV and STI prevalence and determinants among male migrant workers in India.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6c0edb40ccd9bc234c55925cc8726df"><gtr:id>b6c0edb40ccd9bc234c55925cc8726df</gtr:id><gtr:otherNames>Dave SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12563_23_22952708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9B5591E-F030-489D-906D-EE9D1128D260</gtr:id><gtr:title>HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bc871398210973dae1e015c24cf751f"><gtr:id>1bc871398210973dae1e015c24cf751f</gtr:id><gtr:otherNames>Delva W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_12563_23_22802738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB6CE00D-60F9-40C9-B159-92C121ED0288</gtr:id><gtr:title>Population density, water supply, and the risk of dengue fever in Vietnam: cohort study and spatial analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c28e6d1210e5135855d52d989235137"><gtr:id>2c28e6d1210e5135855d52d989235137</gtr:id><gtr:otherNames>Schmidt WP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>jdEw6qo4MCt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF0249A0-3FD8-4C07-92F7-3714AEF32311</gtr:id><gtr:title>The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9640e5ec0a493562ad2a4bee17ef9cc7"><gtr:id>9640e5ec0a493562ad2a4bee17ef9cc7</gtr:id><gtr:otherNames>Odone A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f984984fcd86b8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C376AE-68B7-411E-9084-449735D77976</gtr:id><gtr:title>Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_12563_23_22592824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71808379-BB85-4CCA-A6F7-D9BC196B62AA</gtr:id><gtr:title>Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfe468c29720504dc9f5c556649bd597"><gtr:id>dfe468c29720504dc9f5c556649bd597</gtr:id><gtr:otherNames>Orroth KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>doi_55f984984faddf36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00E598FF-43C5-49AE-98A4-E8A6A3F94F2E</gtr:id><gtr:title>Strong association between in-migration and HIV prevalence in urban sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd31797eb04128b12b1dd098d0a12df2"><gtr:id>cd31797eb04128b12b1dd098d0a12df2</gtr:id><gtr:otherNames>Voeten HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>XohkCPFji2o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E6F7CF4-87F2-4861-B15C-6DB6094F4176</gtr:id><gtr:title>Calibrating models in economic evaluation: a seven-step approach.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e163d72a45e525a7d651db476009374"><gtr:id>5e163d72a45e525a7d651db476009374</gtr:id><gtr:otherNames>Vanni T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>M89tfsBVXE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC90CFE-C80F-4990-AA12-B6773A6E637A</gtr:id><gtr:title>Evaluation of respondent-driven sampling.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255db24a1a1b4ad3a0061f516c1141a4"><gtr:id>255db24a1a1b4ad3a0061f516c1141a4</gtr:id><gtr:otherNames>McCreesh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>MsPVboSK7MW</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802414</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>